VentriPoint Diagnostics Ltd (VPT) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.021x

Based on the latest financial reports, VentriPoint Diagnostics Ltd (VPT) has a cash flow conversion efficiency ratio of 0.021x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-95.70K ≈ $-69.23K USD) by net assets (CA$-4.66 Million ≈ $-3.37 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See VentriPoint Diagnostics Ltd defensive interval ratio to measure how many days the company can operate on defensive assets alone.

VentriPoint Diagnostics Ltd - Cash Flow Conversion Efficiency Trend (2005–2024)

This chart illustrates how VentriPoint Diagnostics Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

VentriPoint Diagnostics Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of VentriPoint Diagnostics Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Precio Fishbone AB (publ) ST:PRCO-B	0.004x
Ugint Co Ltd KQ:195990	-0.020x
Dpi Holdings Berhad KLSE:0205	0.030x
Drillcon AB ST:DRIL	0.073x
Kamdhenu Ventures Limited NSE:KAMOPAINTS	0.003x
Quickfee Ltd AU:QFE	-0.564x
Ping An Biomedical Co., Ltd. NASDAQ:PASW	N/A
HUTCHMED China Ltd LSE:HCM	-0.029x

Annual Cash Flow Conversion Efficiency for VentriPoint Diagnostics Ltd (2005–2024)

The table below shows the annual cash flow conversion efficiency of VentriPoint Diagnostics Ltd from 2005 to 2024. For the full company profile with market capitalisation and key ratios, see how much is VentriPoint Diagnostics Ltd worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CA$-2.98 Million ≈ $-2.16 Million	CA$-3.39 Million ≈ $-2.45 Million	1.136x	+105.66%
2023-12-31	CA$189.71K ≈ $137.23K	CA$-3.80 Million ≈ $-2.75 Million	-20.052x	-2107.17%
2022-12-31	CA$4.55 Million ≈ $3.29 Million	CA$-4.14 Million ≈ $-2.99 Million	-0.908x	-140.60%
2021-12-31	CA$8.33 Million ≈ $6.03 Million	CA$-3.15 Million ≈ $-2.28 Million	-0.378x	-180.59%
2020-12-31	CA$-2.35 Million ≈ $-1.70 Million	CA$-1.10 Million ≈ $-795.98K	0.469x	-51.41%
2019-12-31	CA$-2.47 Million ≈ $-1.79 Million	CA$-2.38 Million ≈ $-1.72 Million	0.964x	-69.22%
2018-12-31	CA$-973.26K ≈ $-704.04K	CA$-3.05 Million ≈ $-2.21 Million	3.133x	+65.95%
2017-12-31	CA$-1.63 Million ≈ $-1.18 Million	CA$-3.07 Million ≈ $-2.22 Million	1.888x	+93.11%
2016-12-31	CA$-2.25 Million ≈ $-1.63 Million	CA$-2.20 Million ≈ $-1.59 Million	0.978x	-83.62%
2015-12-31	CA$-269.66K ≈ $-195.07K	CA$-1.61 Million ≈ $-1.16 Million	5.967x	+1033.35%
2014-12-31	CA$-2.40 Million ≈ $-1.73 Million	CA$-1.26 Million ≈ $-912.31K	0.526x	-36.40%
2013-12-31	CA$-3.12 Million ≈ $-2.26 Million	CA$-2.58 Million ≈ $-1.87 Million	0.828x	-49.84%
2012-12-31	CA$-2.65 Million ≈ $-1.92 Million	CA$-4.37 Million ≈ $-3.16 Million	1.650x	-3.38%
2011-12-31	CA$-2.33 Million ≈ $-1.68 Million	CA$-3.98 Million ≈ $-2.88 Million	1.708x	-27.65%
2010-12-31	CA$-860.17K ≈ $-622.24K	CA$-2.03 Million ≈ $-1.47 Million	2.360x	+434.52%
2009-12-31	CA$-3.26 Million ≈ $-2.36 Million	CA$-1.44 Million ≈ $-1.04 Million	0.442x	-80.32%
2008-12-31	CA$-1.87 Million ≈ $-1.35 Million	CA$-4.20 Million ≈ $-3.04 Million	2.244x	+682.50%
2007-12-31	CA$2.50 Million ≈ $1.81 Million	CA$-965.08K ≈ $-698.12K	-0.385x	-590.65%
2006-12-31	CA$670.44K ≈ $484.98K	CA$-37.40K ≈ $-27.06K	-0.056x	-886.77%
2005-12-31	CA$695.36K ≈ $503.01K	CA$-3.93K ≈ $-2.84K	-0.006x	--

About VentriPoint Diagnostics Ltd

V:VPT Canada Medical Devices

Market Cap

$18.33 Million

CA$25.33 Million CAD

Market Cap Rank

#25385 Global

#1012 in Canada

Share Price

CA$0.14

Change (1 day)

+0.00%

52-Week Range

CA$0.08 - CA$0.17

All Time High

CA$0.69